Survival prediction in patients treated by FOLFIRI and bevacizumab for metastatic colorectal cancer (PRODIGE 9) using contrast-enhanced CT texture analysis (SPECTRA).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Anthony Dohan, Benoit Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Philippe Soyer, Jaafar Bennouna, Francois Ghiringhelli, Valerie Boige, Julien Taieb, Olivier Bouche, Eric Francois, Jean Marc Phelip, Christian Borel, Roger Faroux, Jean-François Seitz, Stephane Jacquot, Come Lepage, Thomas Aparicio, Christine Hoeffel
Institutions: Inserm, Hôpital Lariboisière, McGill University Health Centre, Centre Hospitalier Universitaire de Montpellier, Fédération Francophone de Cancérologie Digestive, Centre Georges François Leclerc, Institut Gustave Roussy, Fondation Gustave Roussy, Hôpital Européen Georges-Pompidou, Centre Hospitalier Universitaire de Reims, Centre Antoine Lacassagne, Institut Strauss, Hôpital de la Timone, Clinique Clémentville, Hôpital Saint-Louis, Hôpital Maison Blanche
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2806368367